Real-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival.
- DOI
- 10.1016/j.acuroe.2026.502033
- Published
- 2026 Aug 3
- Container
- Actas urologicas espanolas
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.acuroe.2026.502033,
title = {Real-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival.},
author = {Samper Ots PM and González Santos D and González Del Portillo E and Valcárcel Díaz A and Engel O and Amaya Escobar E and Sánchez Encinas M and Gimbernat Diaz H and Blázquez Vallejo C and Husillos Alonso A and Ramírez Martín D and Useros Rodríguez E},
year = {2026},
journal = {Actas urologicas espanolas},
doi = {10.1016/j.acuroe.2026.502033},
url = {https://doi.org/10.1016/j.acuroe.2026.502033}
}RIS
TY - JOUR TI - Real-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival. AU - Samper Ots PM AU - González Santos D AU - González Del Portillo E AU - Valcárcel Díaz A AU - Engel O AU - Amaya Escobar E AU - Sánchez Encinas M AU - Gimbernat Diaz H AU - Blázquez Vallejo C AU - Husillos Alonso A AU - Ramírez Martín D AU - Useros Rodríguez E PY - 2026 JO - Actas urologicas espanolas DO - 10.1016/j.acuroe.2026.502033 UR - https://doi.org/10.1016/j.acuroe.2026.502033 ER -
APA
PM, S. O., D, G. S., E, G. D. P., A, V. D., O, E., E, A. E., M, S. E., H, G. D., C, B. V., A, H. A., D, R. M., & E, U. R. (2026). Real-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival.. Actas urologicas espanolas. https://doi.org/10.1016/j.acuroe.2026.502033
Source records
- pubmed · retrieved 2026-09-27T12:25:09.830Z